Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells

American Journal of Pathology

Volumn 148, Issue 5, 1996, Pages 1649-1660

  Silletti, Steve ^a   Paku, Sandor ^a   Raz, Avraham ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOCRINE MOTILITY FACTOR; CYTOKINE; MONOCLONAL ANTIBODY; PHOSPHOTYROSINE;

ANGIOSARCOMA; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR CELL; TUMOR GROWTH;

ANIMALS; AUTOCRINE MOTILITY FACTOR; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELL COMMUNICATION; CELL DIVISION; CELL LINE, TRANSFORMED; CYTOSKELETON; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMANGIOSARCOMA; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTORS, CYTOKINE; TUMOR CELLS, CULTURED; TYROSINE; VINCULIN;

EID: 0029991366     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Erickson CA: Cell migration in the embryo and adult organism. Curr Opin Cell Biol, 1990, 2 67-74
2. Stoker M, Gherardi E: Regulation of cell movement, the motogenic cytokines. Biochem Biophys Acta 1991, 1072:81-102
3. Erdel M, Spiess E, Trefz G, Boxberger H-J, Ebert W Cell interactions and motility in human lung tumor cell lines HS-24 and SB-3 under the influence of extracellular matrix components and proteinase inhibitors. Anticancer Res 1992, 12:349-360
4. McCarthy JB, Furcht LT: Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro. J Cell Biol 1984, 98:1474-1480
5. Liotta LA, Mandler R, Murano G, Katz DA, Gordon RK, Chiang PK, Schiffmann E: Tumor cell autocrine motility factor Proc Natl Acad Sci USA 1986, 83:3302-3306
6. Silletti S, Watanabe H, Hogan V, Nabi IR, Raz A. Purification of B16-F1 melanoma autocrine motility factor and its receptor. Cancer Res 1991, 51:3507-3511
7. Watanabe H, Carmi P, Hogan V, Raz T, Silletti S, Nabi IR, Raz A. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J Biol Chem 1991, 26:13442-13448
8. Stracke ML, Guirguis R, Liotta LA, Schiffmann E. Pertussis toxin inhibits stimulated motility independently of the adenylate cyclase pathway in human melanoma cells Biochem Biophys Res Commun 1987, 146:339-345
9. Kohn EC, Liotta LA, Schiffmann E. Autocrine motility factor stimulates a three-fold increase in inositol triphosphate in human melanoma cells Biochem Biophys Res Commun 1990, 166:757-764
10. Timar J, Silletti S, Bazaz R, Raz A, Honn KV: Regulation of melanoma cell motility by the lipoxygenase metabolite 12-(S)-HETE. Int J Cancer 1993, 55:1003-1010
11. Silletti S, Timar J, Honn KV, Raz A: Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high and low metastatic K1735 melanoma cells. Cancer Res 1994, 54:5752-5756
12. Benlimame N, Simard D, Nabi IR: Autocrine motility factor receptor is a marker for a distinct membranous tubular organelle. J Cell Biol 1995, 129:459-471
13. Van Roy FV, Mareel M. Tumour invasion, effects of cell adhesion and motility Trends Cell Biol 1992, 2:163-169
14. Silletti S, Yao J, Sanford J, Mohammed A, Otto T, Wolman SR, Raz A: Autocrine motility factor receptor in human bladder carcinoma, gene expression, loss of cell-contact regulation and chromosomal mapping. Int J Oncol 1993, 3:801-807
15. Otto T, Birchmeier W, Schmidt U, Hinke A, Schipper J, Rubben H, Raz A Inverse relation of E-cadherin and autocrine motility factor expression as a prognostic factor in patients with bladder carcinomas Cancer Res 1994, 54:3120-3123
16. Doyle GM, Sharief Y, Mohler JL. Prediction of metastatic potential by cancer cell motility in the Dunning R-3327 prostatic adenocarcinoma in vivo model J Urol 1992, 147:514-518
17. Nakamori S, Watanabe H, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, Kabuto T, Iwanaga T, Ishiguro S, Raz A: Expression of autocrine motility factor receptor, AMF-R, in colorectal cancer, a predictor of disease recurrence Cancer 1994, 74:1855-1862
18. Silletti S, Yao J, Pienta KJ, Raz, A: Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells. Int J Cancer 1995, 63:100-105
19. Ishisaki A, Oida S, Momose F, Amagasa T, Rikimaru K, Ichijo H: Identification and characterization of autocrine-motility-factor-like activity in oral squamous-cell-carcinoma cells. Int J Cancer 1994, 59:783-788
20. Silletti S, Raz A. Autocrine motility factor is a growth factor. Biochem Biophys Res Commun 1993, 194:446-457
21. Zvibel I, Raz A: The establishment and characterization of a new Balb/c angiosarcoma tumor system Int J Cancer 1985, 36:261-272
22. Nabi IR, Raz A: Cell shape modulation alters glycosylation of a metastatic melanoma cell-surface antigen. Cancer Res 1987, 48 396-402
23. Samuels M, Ezzell RM, Cardozo TJ, Critchley DR, Coll J-L, Adamson ED: Expression of chicken vinculin complements the adhesion-defective phenotype of a mutant mouse F9 embryonal carcinoma cell J Cell Biol 1993, 121 909-921
24. FAK, to cellular focal adhesions. J Cell Biol 1993, 123:993-1005
25. Watanabe H, Nabi IR, Raz A: The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells. Cancer Res 1991, 51:2699-2705
26. Fernandez JLR, Geiger B, Saloman D, Ben-Ze'ev A: Suppression of vinculin expression by antisense transfection confers changes in cell morphology, motility, and anchorage-dependent growth of 3T3 cells. J Cell Biol 1993, 122:1285-1294
27. Romer LH, Burridge K, Turner CE: Signaling between the extracellular matrix and the cytoskeleton. tyrosine phosphorylation and focal adhesion assembly Cold Spring Harbor Symp Quant Biol 1992, 57 193-202
28. Liotta LA, Stracke ML, Aznavoorian SA, Beckner ME, Schiffmann E. Tumor cell motility. Semin Cancer Biol 1991, 2:111-114
29. Nabi IR, Watanabe H, Raz A: Autocrine motility factor and its receptor role in cell locomotion and metastasis Cancer Metastasis Rev 1992, 11:5-20
30. Hendrix MJC, Wood WR, Seftor EA, Lotan D, Nakajima M, Misiorowski RL, Seftor REB, Stetler-Stevenson WG, Bavacqua SJ, Liotta LA, Sobel ME, Raz A, Lotan R: Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res 1990, 50:121-4130
31. Lotan R, Amos B, Watanabe H, Raz A: Suppression of motility factor receptor expression by retinoic acid Cancer Res 1992, 52:4878-4884
32. Nabi IR, Watanabe H, Raz A: Identification of B16-F1 melanoma autocrine motility-like factor receptor. Cancer Res 1990, 50:409-414
33. Guirguis R, Margulies I, Taraboletti G, Schiffmann E, Liotta L: Cytokine-induced pseudopodial protrusion is coupled to tumor cell migration. Nature 1987, 329:261-263
34. Volk T, Geiger B, Raz A: Motility and adhesive properties of high- and low-metastatic murine neoplastic cells. Cancer Res 1984, 44:811-824
35. Raz A, Geiger B: Altered organization of cell-substrate contacts and membrane-associated cytoskeleton in tumor cell variants exhibiting different metastatic capabilities. Cancer Res 1982, 42:5183-5190
36. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT: pp125FAK, a structurally distinctive protein-tyrosine kinase associated with focal adhesions Proc Natl Acad Sci USA 1992, 89:5192-5196
37. Burridge K, Fath K, Kelly T, Nuckolls G, Turner CE: Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton. Annu Rev Cell Biol 1988, 4 487-525
38. Parsons JT, Weber MJ: Genetics of src. structure and functional organization of a protein tyrosine kinase Curr Top Microbiol Immunol 1989, 147:79-127
39. Hartmann G, Weidner KM, Schwartz H, Birchmeier W: The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of ras. J Biol Chem 1994, 269:21936-21939
40. Hall CL, Wang C, Lange LA, Turley EA Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J Cell Biol 1994, 126:575-588
41. Bornfeldt KE, Graves LE, Raines EW, Igarashi Y, Wayman G, Yamamura S, Yatomi Y, Sidhu JS, Krebs EG, Hakamori S-I, Ross R: Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction. J Cell Biol 1995, 130: 193-206